Dr. Oke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Holcombe BLVD
Houston, TX 77030Phone+1 713-792-0085
Summary
- Dr. Oluchi Oke is an oncologist based in Houston, Texas. She completed her medical degree at the University of Illinois College of Medicine in 2013, her residency in Internal Medicine at Vanderbilt University Medical Center from 2013 to 2016, and her Hematology and Medical Oncology fellowship at University of Texas Health Science Center at Houston/M D Anderson Cancer Center from 2016 to 2019. Presently, she works as an Assistant Professor at University of Texas M.D. Anderson Cancer Center. Dr. Oke has experience in treating cancer-associated retinopathy and has a strong record of research and publication, with her work appearing in NPJ Breast Cancer, JAMA Network Open, Cancer and European Urology among others.
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2013 - 2016
- University of Illinois College of MedicineClass of 2013
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2017 - 2026
- TN State Medical License 2015 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 6 citationsOutcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis.Oluchi Oke, Tarsheen K. Sethi, Stacey Goodman, Sharon Phillips, Ilka Decker
Biology of Blood and Marrow Transplantation. 2017-09-01 - 40 citationsCharacterization of bone only metastasis patients with respect to tumor subtypes.Amanda Parkes, Katherine Clifton, Aydah Al-Awadhi, Oluchi Oke, Carla L. Warneke
NPJ Breast Cancer. 2018-01-25 - 43 citationsPrognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only MetastasesAmanda Parkes, Carla L. Warneke, Katherine Clifton, Aydah Al-Awadhi, Oluchi Oke
The Oncologist. 2018-11-01
Press Mentions
- Triple-Negative Breast Cancer Survivor: MD Anderson Is ‘A Hospital like No Other’January 24th, 2023
- The Urgent Need for ResearchJanuary 3rd, 2023
- Breast Cancer Survivor: Why I Chose MD Anderson for Treatment During My Second PregnancyJuly 14th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: